Flash Finance

CCME Global Ltd514336Corporate

Biotechnology Latest results: Jun 2026 14 quarters of data
₹33.07
MCap ₹150 Cr
CCME Global Ltd — Stock analysis & AI research CCME Global Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Jun 2026
₹-0 Cr
Operating Profit · Jun 2026
-101.3% YoY
—
OPM % · Jun 2026
₹-0 Cr
Net Profit · Jun 2026
-120.2% YoY
₹-0.06
EPS · Jun 2026
+33.3% YoY

📝 CCME Global Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

CCME Global Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), and down 100.0% sequentially over the March 2026 quarter.

The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.06.

Full year and trailing twelve months

For the full year FY26, CCME Global Ltd posted revenue of ₹0 crore, a decline of 98.9% over FY25, with a net loss of ₹1 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹1 crore.

Valuation snapshot

At the current price of ₹33.07, 514336 has a market capitalisation of ₹150 crore.

Within the Biotechnology industry, it is the 5th-largest of the 8 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 74.35%, public shareholders 25.65% of CCME Global Ltd.

Promoter holding rose from 74.17% to 74.35% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹150 Cr
Current Price ?
₹33.1
P/E ?
N/A
Industry P/E ?
106.70
P/B ?
3.73
P/S ?
3,741.04
P/FCF ?
29.34
Enterprise Value ?
₹150 Cr
EV/EBITDA ?
-179.94
PEG ?
N/A
Earnings Yield ?
-0.6%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹0 Cr
OPM ?
-2,079.0%
Profit after tax (TTM) ?
₹-1 Cr
EPS (TTM) ?
₹-0.19
ROCE ?
-2.9%
ROE ?
-2.1%
ROA ?
-1.9%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹-0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
-120.2%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
74.35%
Change in promoter holding ?
63.02%
Pledged percentage ?
N/A
Market
Return 3 months ?
-70.8%
Return 6 months ?
-67.3%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 00000040000000 — -100.0%
Operating Profit -0-0-0-0-4-04-0-0-0-0-0-0-0 -101.3% +51.7%
Other Income 00000000000000 — —
Interest 00000000000000 — —
Depreciation 00000000000000 — —
Profit Before Tax -0-0-0-0-4-04-0-0-0-0-0-0-0 -120.2% +47.2%
Net Profit -0-0-0-0-4-04-0-0-0-0-0-0-0 -120.2% +47.2%
EPS -0.04-0.05-0.02-0.02-2.84-0.082.81-0.02-0.02-0.09-0.05-0.02-0.11-0.06 +33.3% +45.5%
OPM % — — — — — — 99.5% — — — — — -1250.0% — — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹4 Cr ₹0 Cr ₹0 Cr -98.9%
Operating Profit ₹4 Cr ₹-1 Cr ₹-1 Cr -120.3%
OPM % 95.37% -1,775.00% -2,079.00% -1961.2%
NPM % 95.37% -1,775.00% -2,135.50% -1961.2%
Other Income ₹0 Cr ₹0 Cr ₹0 Cr —
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr —
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹4 Cr ₹-1 Cr ₹-1 Cr -120.3%
PBT ₹4 Cr ₹-1 Cr ₹-1 Cr -120.3%
Tax — — ₹0 Cr —
Net Profit ₹4 Cr ₹-1 Cr ₹-1 Cr -120.3%
EPS ₹2.69 ₹-0.27 ₹-0.24 -110.0%
Material Cost — — ₹0 Cr —
Employee Cost — — ₹0 Cr —
Extraordinary Items — — ₹0 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 13.0013.0013.0045.25 +248.1%
Reserves -4.17-7.97-4.47-5.18 -15.9%
Borrowings 0.000.000.000.00 —
Other Liabilities 0.140.180.305.24 +1646.7%
Total Liabilities 8.975.218.8345.31 +413.1%
Fixed Assets 0.000.000.000.00 —
CWIP 0.000.000.000.00 —
Investments 0.000.000.000.00 —
Other Assets 8.975.218.8345.31 +413.1%
Total Assets 8.975.218.8345.31 +413.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -0.090.000.005.10 —
Cash from Investing Activity 0.000.000.000.00 —
Cash from Financing Activity 0.090.000.0032.25 —
Net Cash Flow -0.010.000.0037.35 —
Free Cash Flow -0.090.000.005.10 —
CFO/OP 64%0%0%-718% —

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days ———0.00 —
Cash Conversion Cycle ———0.00 —
Working Capital Days ———24,728.75 —
ROCE % -1.57%-54.83%51.62%-2.92% -105.7%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 11.33%11.33%74.17%74.35% +0.2%
Public 88.68%88.68%25.83%25.65% -0.7%
No. of Shareholders 1,7361,8551,9381,937 -0.1%

⚖️ Peer comparison

Industry: Biotechnology · 8 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 BIOCON Biocon ₹390.65 63,609 147.4 17,322 417 20.4% 2.4% 10.9% -74.2% 10.0% 53.4%
2 ANTHEM ANTHEM BIOSCIENCES ₹874.85 49,142 85.4 2,002 576 39.6% 28.8% — — -22.6% -11.7%
3 ONESOURCE ONESOURCE SPECL ₹1,592.00 18,256 — 1,544 -49 21.9% -3.2% -1.6% -185.0% 37.3% 0.7%
4 CONCORDBIO Concord Biotech ₹1,510.00 15,797 57.6 1,109 273 34.9% 24.6% -12.1% -30.4% 26.2% 31.0%
5 514336 CCME Global ₹15.10 150 — 0 -1 -2079.0% -2135.5% -98.9% -120.3% — -120.2%
6 511509 Vivo Bio ₹37.69 37 — 55 -3 37.0% -5.2% 14.3% -123.4% 14.1% -86.0%
7 539470 Shree Ganesh ₹1.20 18 — 5 -0 -35.3% -7.8% -78.4% 34.2% 3.6% -273.7%
8 539206 Genomic Valley ₹52.00 9 n/m 0 0 11.7% 6.7% -68.2% -94.4% -57.8% -26.9%
❓ Frequently asked questions
What was CCME Global Ltd's revenue in Q1 FY27?
CCME Global Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), and down 100.0% sequentially over the March 2026 quarter.
What was CCME Global Ltd's net profit in Q1 FY27?
The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.06.
What is 514336's market capitalisation and P/E ratio?
At the current price of ₹33.07, 514336 has a market capitalisation of ₹150 crore.
Who owns CCME Global Ltd? (shareholding pattern)
As of Jun 2026, promoters held 74.35%, public shareholders 25.65% of CCME Global Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI